APO Research, Inc.

APO RESEARCH · REPORT

Bovine Blood Products

Selected research

Market Outlook & Growth Opportunities

Global Bovine Blood Products Market Outlook and Growth Opportunities 2026

Market perspective

The global Bovine Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bovine Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bovine Blood Products market include Animal Technologies, Bio Nutrientes Brasil, Biological Industries, Biowest, Bovogen, Cytiva, ExCell Bio, Gemini and Internegocios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bovine Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bovine Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bovine Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bovine Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Bovine Blood Products Segment by Company

Animal Technologies

Bio Nutrientes Brasil

Biological Industries

Biowest

Bovogen

Cytiva

ExCell Bio

Gemini

Internegocios

Moregate BioTech

NorthBio

PAN-Biotech

Peak Serum

R&D Systems

RMBIO

Serana

Seroxlab

Tissue Culture Biologicals

VWR

WISENT

Corning

Lanzhou Minhai

Merck

Jin Yuan Kang

Thermo Fisher

Zhejiang Tianhang Biotechnology

Bovine Blood Products Segment by Type

Bovine / Cow

Fetal Bovine

Others

Bovine Blood Products Segment by Application

Scientific Research

Industrial Production

Bovine Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bovine Blood Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bovine Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bovine Blood Products significant trends, drivers, influence factors in global and regions.

6. To analyze Bovine Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bovine Blood Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bovine Blood Products industry.

Chapter 3: Detailed analysis of Bovine Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bovine Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bovine Blood Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bovine Blood Products Industry Trends Table 2. Bovine Blood Products Industry Drivers Table 3. Bovine Blood Products Industry Opportunities and Challenges Table 4. Bovine Blood Products Industry Restraints Table 5. Global Bovine Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bovine Blood Products Revenue Share by Company (2021-2026) Table 7. Global Bovine Blood Products Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Bovine Blood Products Sales Volume Share by Company (2021-2026) Table 9. Global Bovine Blood Products Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bovine Blood Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bovine Blood Products Key Company Manufacturing Base & Headquarters Table 12. Global Bovine Blood Products Company, Product Type & Application Table 13. Global Bovine Blood Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bovine Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bovine / Cow Table 18. Significant Companies of Fetal Bovine Table 19. Significant Companies of Others Table 20. Global Bovine Blood Products Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Bovine Blood Products Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Bovine Blood Products Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Bovine Blood Products Sales Volume Share by Type (2021-2026) Table 24. Global Bovine Blood Products Sales Volume Share by Type (2027-2032) Table 25. Global Bovine Blood Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bovine Blood Products Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bovine Blood Products Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bovine Blood Products Sales Value Share by Type (2021-2026) Table 29. Global Bovine Blood Products Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Scientific Research Table 31. Significant Companies of Industrial Production Table 32. Global Bovine Blood Products Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Bovine Blood Products Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Bovine Blood Products Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Bovine Blood Products Sales Volume Share by Application (2021-2026) Table 36. Global Bovine Blood Products Sales Volume Share by Application (2027-2032) Table 37. Global Bovine Blood Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bovine Blood Products Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bovine Blood Products Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bovine Blood Products Sales Value Share by Application (2021-2026) Table 41. Global Bovine Blood Products Sales Value Share by Application (2027-2032) Table 42. Global Bovine Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Bovine Blood Products Sales by Region (2021-2026) & (K Units) Table 44. Global Bovine Blood Products Sales Market Share by Region (2021-2026) Table 45. Global Bovine Blood Products Sales by Region (2027-2032) & (K Units) Table 46. Global Bovine Blood Products Sales Market Share by Region (2027-2032) Table 47. Global Bovine Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bovine Blood Products Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bovine Blood Products Sales Value Share by Region (2021-2026) Table 50. Global Bovine Blood Products Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bovine Blood Products Sales Value Share by Region (2027-2032) Table 52. Global Bovine Blood Products Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bovine Blood Products Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bovine Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Bovine Blood Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bovine Blood Products Sales by Country (2021-2026) & (K Units) Table 57. Global Bovine Blood Products Sales Market Share by Country (2021-2026) Table 58. Global Bovine Blood Products Sales by Country (2027-2032) & (K Units) Table 59. Global Bovine Blood Products Sales Market Share by Country (2027-2032) Table 60. Global Bovine Blood Products Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bovine Blood Products Sales Value Market Share by Country (2021-2026) Table 62. Global Bovine Blood Products Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bovine Blood Products Sales Value Market Share by Country (2027-2032) Table 64. Animal Technologies Company Information Table 65. Animal Technologies Business Overview Table 66. Animal Technologies Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Animal Technologies Bovine Blood Products Product Portfolio Table 68. Animal Technologies Recent Development Table 69. Bio Nutrientes Brasil Company Information Table 70. Bio Nutrientes Brasil Business Overview Table 71. Bio Nutrientes Brasil Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bio Nutrientes Brasil Bovine Blood Products Product Portfolio Table 73. Bio Nutrientes Brasil Recent Development Table 74. Biological Industries Company Information Table 75. Biological Industries Business Overview Table 76. Biological Industries Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biological Industries Bovine Blood Products Product Portfolio Table 78. Biological Industries Recent Development Table 79. Biowest Company Information Table 80. Biowest Business Overview Table 81. Biowest Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Biowest Bovine Blood Products Product Portfolio Table 83. Biowest Recent Development Table 84. Bovogen Company Information Table 85. Bovogen Business Overview Table 86. Bovogen Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bovogen Bovine Blood Products Product Portfolio Table 88. Bovogen Recent Development Table 89. Cytiva Company Information Table 90. Cytiva Business Overview Table 91. Cytiva Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cytiva Bovine Blood Products Product Portfolio Table 93. Cytiva Recent Development Table 94. ExCell Bio Company Information Table 95. ExCell Bio Business Overview Table 96. ExCell Bio Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ExCell Bio Bovine Blood Products Product Portfolio Table 98. ExCell Bio Recent Development Table 99. Gemini Company Information Table 100. Gemini Business Overview Table 101. Gemini Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Gemini Bovine Blood Products Product Portfolio Table 103. Gemini Recent Development Table 104. Internegocios Company Information Table 105. Internegocios Business Overview Table 106. Internegocios Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Internegocios Bovine Blood Products Product Portfolio Table 108. Internegocios Recent Development Table 109. Moregate BioTech Company Information Table 110. Moregate BioTech Business Overview Table 111. Moregate BioTech Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Moregate BioTech Bovine Blood Products Product Portfolio Table 113. Moregate BioTech Recent Development Table 114. NorthBio Company Information Table 115. NorthBio Business Overview Table 116. NorthBio Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. NorthBio Bovine Blood Products Product Portfolio Table 118. NorthBio Recent Development Table 119. PAN-Biotech Company Information Table 120. PAN-Biotech Business Overview Table 121. PAN-Biotech Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. PAN-Biotech Bovine Blood Products Product Portfolio Table 123. PAN-Biotech Recent Development Table 124. Peak Serum Company Information Table 125. Peak Serum Business Overview Table 126. Peak Serum Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Peak Serum Bovine Blood Products Product Portfolio Table 128. Peak Serum Recent Development Table 129. R&D Systems Company Information Table 130. R&D Systems Business Overview Table 131. R&D Systems Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. R&D Systems Bovine Blood Products Product Portfolio Table 133. R&D Systems Recent Development Table 134. RMBIO Company Information Table 135. RMBIO Business Overview Table 136. RMBIO Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. RMBIO Bovine Blood Products Product Portfolio Table 138. RMBIO Recent Development Table 139. Serana Company Information Table 140. Serana Business Overview Table 141. Serana Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Serana Bovine Blood Products Product Portfolio Table 143. Serana Recent Development Table 144. Seroxlab Company Information Table 145. Seroxlab Business Overview Table 146. Seroxlab Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Seroxlab Bovine Blood Products Product Portfolio Table 148. Seroxlab Recent Development Table 149. Tissue Culture Biologicals Company Information Table 150. Tissue Culture Biologicals Business Overview Table 151. Tissue Culture Biologicals Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Tissue Culture Biologicals Bovine Blood Products Product Portfolio Table 153. Tissue Culture Biologicals Recent Development Table 154. VWR Company Information Table 155. VWR Business Overview Table 156. VWR Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. VWR Bovine Blood Products Product Portfolio Table 158. VWR Recent Development Table 159. WISENT Company Information Table 160. WISENT Business Overview Table 161. WISENT Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. WISENT Bovine Blood Products Product Portfolio Table 163. WISENT Recent Development Table 164. Corning Company Information Table 165. Corning Business Overview Table 166. Corning Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Corning Bovine Blood Products Product Portfolio Table 168. Corning Recent Development Table 169. Lanzhou Minhai Company Information Table 170. Lanzhou Minhai Business Overview Table 171. Lanzhou Minhai Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Lanzhou Minhai Bovine Blood Products Product Portfolio Table 173. Lanzhou Minhai Recent Development Table 174. Merck Company Information Table 175. Merck Business Overview Table 176. Merck Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Merck Bovine Blood Products Product Portfolio Table 178. Merck Recent Development Table 179. Jin Yuan Kang Company Information Table 180. Jin Yuan Kang Business Overview Table 181. Jin Yuan Kang Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Jin Yuan Kang Bovine Blood Products Product Portfolio Table 183. Jin Yuan Kang Recent Development Table 184. Thermo Fisher Company Information Table 185. Thermo Fisher Business Overview Table 186. Thermo Fisher Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Thermo Fisher Bovine Blood Products Product Portfolio Table 188. Thermo Fisher Recent Development Table 189. Zhejiang Tianhang Biotechnology Company Information Table 190. Zhejiang Tianhang Biotechnology Business Overview Table 191. Zhejiang Tianhang Biotechnology Bovine Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 192. Zhejiang Tianhang Biotechnology Bovine Blood Products Product Portfolio Table 193. Zhejiang Tianhang Biotechnology Recent Development Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Bovine Blood Products Distributors List Table 197. Bovine Blood Products Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Bovine Blood Products Product Image Figure 2. Global Bovine Blood Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Blood Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bovine Blood Products Sales (2021-2032) & (K Units) Figure 5. Global Bovine Blood Products Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bovine Blood Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bovine / Cow Image Figure 10. Fetal Bovine Image Figure 11. Others Image Figure 12. Global Bovine Blood Products Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Bovine Blood Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bovine Blood Products Sales Volume Share by Type (2021-2032) Figure 15. Global Bovine Blood Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bovine Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bovine Blood Products Sales Value Share by Type (2021-2032) Figure 18. Scientific Research Image Figure 19. Industrial Production Image Figure 20. Global Bovine Blood Products Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Bovine Blood Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bovine Blood Products Sales Volume Share by Application (2021-2032) Figure 23. Global Bovine Blood Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bovine Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bovine Blood Products Sales Value Share by Application (2021-2032) Figure 26. Global Bovine Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Bovine Blood Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bovine Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bovine Blood Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bovine Blood Products Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bovine Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bovine Blood Products Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bovine Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bovine Blood Products Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bovine Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bovine Blood Products Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bovine Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bovine Blood Products Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bovine Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bovine Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bovine Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bovine Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bovine Blood Products Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bovine Blood Products Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine / Cow
  • Fetal Bovine
  • Others
Applications
  • Scientific Research
  • Industrial Production
Companies covered
  • Animal Technologies
  • Bio Nutrientes Brasil
  • Biological Industries
  • Biowest
  • Bovogen
  • Cytiva
  • ExCell Bio
  • Gemini
  • Internegocios
  • Moregate BioTech
  • NorthBio
  • PAN-Biotech
  • Peak Serum
  • R&D Systems
  • RMBIO
  • Serana
  • Seroxlab
  • Tissue Culture Biologicals
  • VWR
  • WISENT
  • Corning
  • Lanzhou Minhai
  • Merck
  • Jin Yuan Kang
  • Thermo Fisher
  • Zhejiang Tianhang Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bovine Blood Products Sales Value (2021-2032)
  4. 1.2.2 Global Bovine Blood Products Sales Volume (2021-2032)
  5. 1.2.3 Global Bovine Blood Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bovine Blood Products Market Dynamics
  1. 2.1 Bovine Blood Products Industry Trends
  2. 2.2 Bovine Blood Products Industry Drivers
  3. 2.3 Bovine Blood Products Industry Opportunities and Challenges
  4. 2.4 Bovine Blood Products Industry Restraints
3 Bovine Blood Products Market by Company
  1. 3.1 Global Bovine Blood Products Company Revenue Ranking in 2025
  2. 3.2 Global Bovine Blood Products Revenue by Company (2021-2026)
  3. 3.3 Global Bovine Blood Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Bovine Blood Products Average Price by Company (2021-2026)
  5. 3.5 Global Bovine Blood Products Company Ranking (2024-2026)
  6. 3.6 Global Bovine Blood Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Bovine Blood Products Company Product Type and Application
  8. 3.8 Global Bovine Blood Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bovine Blood Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bovine Blood Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bovine Blood Products Market by Type
  1. 4.1 Bovine Blood Products Type Introduction
  2. 4.1.1 Bovine / Cow
  3. 4.1.2 Fetal Bovine
  4. 4.1.3 Others
  5. 4.2 Global Bovine Blood Products Sales Volume by Type
  6. 4.2.1 Global Bovine Blood Products Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bovine Blood Products Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bovine Blood Products Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bovine Blood Products Sales Value by Type
  10. 4.3.1 Global Bovine Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bovine Blood Products Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bovine Blood Products Sales Value Share by Type (2021-2032)
5 Bovine Blood Products Market by Application
  1. 5.1 Bovine Blood Products Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Industrial Production
  4. 5.2 Global Bovine Blood Products Sales Volume by Application
  5. 5.2.1 Global Bovine Blood Products Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bovine Blood Products Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Bovine Blood Products Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Bovine Blood Products Sales Value by Application
  9. 5.3.1 Global Bovine Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bovine Blood Products Sales Value by Application (2021-2032)
  11. 5.3.3 Global Bovine Blood Products Sales Value Share by Application (2021-2032)
6 Bovine Blood Products Regional Sales and Value Analysis
  1. 6.1 Global Bovine Blood Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bovine Blood Products Sales by Region (2021-2032)
  3. 6.2.1 Global Bovine Blood Products Sales by Region: 2021-2026
  4. 6.2.2 Global Bovine Blood Products Sales by Region (2027-2032)
  5. 6.3 Global Bovine Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bovine Blood Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bovine Blood Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bovine Blood Products Sales Value by Region (2027-2032)
  9. 6.5 Global Bovine Blood Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bovine Blood Products Sales Value (2021-2032)
  12. 6.6.2 North America Bovine Blood Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bovine Blood Products Sales Value (2021-2032)
  15. 6.7.2 Europe Bovine Blood Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bovine Blood Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bovine Blood Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bovine Blood Products Sales Value (2021-2032)
  21. 6.9.2 South America Bovine Blood Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bovine Blood Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bovine Blood Products Sales Value Share by Country, 2025 VS 2032
7 Bovine Blood Products Country-level Sales and Value Analysis
  1. 7.1 Global Bovine Blood Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bovine Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bovine Blood Products Sales by Country (2021-2032)
  4. 7.3.1 Global Bovine Blood Products Sales by Country (2021-2026)
  5. 7.3.2 Global Bovine Blood Products Sales by Country (2027-2032)
  6. 7.4 Global Bovine Blood Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bovine Blood Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bovine Blood Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bovine Blood Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bovine Blood Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bovine Blood Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bovine Blood Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bovine Blood Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bovine Blood Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bovine Blood Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bovine Blood Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bovine Blood Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bovine Blood Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bovine Blood Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bovine Blood Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bovine Blood Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bovine Blood Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bovine Blood Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bovine Blood Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bovine Blood Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bovine Blood Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bovine Blood Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bovine Blood Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bovine Blood Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bovine Blood Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bovine Blood Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bovine Blood Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bovine Blood Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bovine Blood Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bovine Blood Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bovine Blood Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bovine Blood Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bovine Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Animal Technologies
  2. 8.1.1 Animal Technologies Company Information
  3. 8.1.2 Animal Technologies Business Overview
  4. 8.1.3 Animal Technologies Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Animal Technologies Bovine Blood Products Product Portfolio
  6. 8.1.5 Animal Technologies Recent Developments
  7. 8.2 Bio Nutrientes Brasil
  8. 8.2.1 Bio Nutrientes Brasil Company Information
  9. 8.2.2 Bio Nutrientes Brasil Business Overview
  10. 8.2.3 Bio Nutrientes Brasil Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bio Nutrientes Brasil Bovine Blood Products Product Portfolio
  12. 8.2.5 Bio Nutrientes Brasil Recent Developments
  13. 8.3 Biological Industries
  14. 8.3.1 Biological Industries Company Information
  15. 8.3.2 Biological Industries Business Overview
  16. 8.3.3 Biological Industries Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biological Industries Bovine Blood Products Product Portfolio
  18. 8.3.5 Biological Industries Recent Developments
  19. 8.4 Biowest
  20. 8.4.1 Biowest Company Information
  21. 8.4.2 Biowest Business Overview
  22. 8.4.3 Biowest Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biowest Bovine Blood Products Product Portfolio
  24. 8.4.5 Biowest Recent Developments
  25. 8.5 Bovogen
  26. 8.5.1 Bovogen Company Information
  27. 8.5.2 Bovogen Business Overview
  28. 8.5.3 Bovogen Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bovogen Bovine Blood Products Product Portfolio
  30. 8.5.5 Bovogen Recent Developments
  31. 8.6 Cytiva
  32. 8.6.1 Cytiva Company Information
  33. 8.6.2 Cytiva Business Overview
  34. 8.6.3 Cytiva Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cytiva Bovine Blood Products Product Portfolio
  36. 8.6.5 Cytiva Recent Developments
  37. 8.7 ExCell Bio
  38. 8.7.1 ExCell Bio Company Information
  39. 8.7.2 ExCell Bio Business Overview
  40. 8.7.3 ExCell Bio Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ExCell Bio Bovine Blood Products Product Portfolio
  42. 8.7.5 ExCell Bio Recent Developments
  43. 8.8 Gemini
  44. 8.8.1 Gemini Company Information
  45. 8.8.2 Gemini Business Overview
  46. 8.8.3 Gemini Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gemini Bovine Blood Products Product Portfolio
  48. 8.8.5 Gemini Recent Developments
  49. 8.9 Internegocios
  50. 8.9.1 Internegocios Company Information
  51. 8.9.2 Internegocios Business Overview
  52. 8.9.3 Internegocios Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Internegocios Bovine Blood Products Product Portfolio
  54. 8.9.5 Internegocios Recent Developments
  55. 8.10 Moregate BioTech
  56. 8.10.1 Moregate BioTech Company Information
  57. 8.10.2 Moregate BioTech Business Overview
  58. 8.10.3 Moregate BioTech Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Moregate BioTech Bovine Blood Products Product Portfolio
  60. 8.10.5 Moregate BioTech Recent Developments
  61. 8.11 NorthBio
  62. 8.11.1 NorthBio Company Information
  63. 8.11.2 NorthBio Business Overview
  64. 8.11.3 NorthBio Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 NorthBio Bovine Blood Products Product Portfolio
  66. 8.11.5 NorthBio Recent Developments
  67. 8.12 PAN-Biotech
  68. 8.12.1 PAN-Biotech Company Information
  69. 8.12.2 PAN-Biotech Business Overview
  70. 8.12.3 PAN-Biotech Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 PAN-Biotech Bovine Blood Products Product Portfolio
  72. 8.12.5 PAN-Biotech Recent Developments
  73. 8.13 Peak Serum
  74. 8.13.1 Peak Serum Company Information
  75. 8.13.2 Peak Serum Business Overview
  76. 8.13.3 Peak Serum Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Peak Serum Bovine Blood Products Product Portfolio
  78. 8.13.5 Peak Serum Recent Developments
  79. 8.14 R&D Systems
  80. 8.14.1 R&D Systems Company Information
  81. 8.14.2 R&D Systems Business Overview
  82. 8.14.3 R&D Systems Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 R&D Systems Bovine Blood Products Product Portfolio
  84. 8.14.5 R&D Systems Recent Developments
  85. 8.15 RMBIO
  86. 8.15.1 RMBIO Company Information
  87. 8.15.2 RMBIO Business Overview
  88. 8.15.3 RMBIO Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 RMBIO Bovine Blood Products Product Portfolio
  90. 8.15.5 RMBIO Recent Developments
  91. 8.16 Serana
  92. 8.16.1 Serana Company Information
  93. 8.16.2 Serana Business Overview
  94. 8.16.3 Serana Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Serana Bovine Blood Products Product Portfolio
  96. 8.16.5 Serana Recent Developments
  97. 8.17 Seroxlab
  98. 8.17.1 Seroxlab Company Information
  99. 8.17.2 Seroxlab Business Overview
  100. 8.17.3 Seroxlab Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Seroxlab Bovine Blood Products Product Portfolio
  102. 8.17.5 Seroxlab Recent Developments
  103. 8.18 Tissue Culture Biologicals
  104. 8.18.1 Tissue Culture Biologicals Company Information
  105. 8.18.2 Tissue Culture Biologicals Business Overview
  106. 8.18.3 Tissue Culture Biologicals Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Tissue Culture Biologicals Bovine Blood Products Product Portfolio
  108. 8.18.5 Tissue Culture Biologicals Recent Developments
  109. 8.19 VWR
  110. 8.19.1 VWR Company Information
  111. 8.19.2 VWR Business Overview
  112. 8.19.3 VWR Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 VWR Bovine Blood Products Product Portfolio
  114. 8.19.5 VWR Recent Developments
  115. 8.20 WISENT
  116. 8.20.1 WISENT Company Information
  117. 8.20.2 WISENT Business Overview
  118. 8.20.3 WISENT Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 WISENT Bovine Blood Products Product Portfolio
  120. 8.20.5 WISENT Recent Developments
  121. 8.21 Corning
  122. 8.21.1 Corning Company Information
  123. 8.21.2 Corning Business Overview
  124. 8.21.3 Corning Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Corning Bovine Blood Products Product Portfolio
  126. 8.21.5 Corning Recent Developments
  127. 8.22 Lanzhou Minhai
  128. 8.22.1 Lanzhou Minhai Company Information
  129. 8.22.2 Lanzhou Minhai Business Overview
  130. 8.22.3 Lanzhou Minhai Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Lanzhou Minhai Bovine Blood Products Product Portfolio
  132. 8.22.5 Lanzhou Minhai Recent Developments
  133. 8.23 Merck
  134. 8.23.1 Merck Company Information
  135. 8.23.2 Merck Business Overview
  136. 8.23.3 Merck Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Merck Bovine Blood Products Product Portfolio
  138. 8.23.5 Merck Recent Developments
  139. 8.24 Jin Yuan Kang
  140. 8.24.1 Jin Yuan Kang Company Information
  141. 8.24.2 Jin Yuan Kang Business Overview
  142. 8.24.3 Jin Yuan Kang Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Jin Yuan Kang Bovine Blood Products Product Portfolio
  144. 8.24.5 Jin Yuan Kang Recent Developments
  145. 8.25 Thermo Fisher
  146. 8.25.1 Thermo Fisher Company Information
  147. 8.25.2 Thermo Fisher Business Overview
  148. 8.25.3 Thermo Fisher Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Thermo Fisher Bovine Blood Products Product Portfolio
  150. 8.25.5 Thermo Fisher Recent Developments
  151. 8.26 Zhejiang Tianhang Biotechnology
  152. 8.26.1 Zhejiang Tianhang Biotechnology Company Information
  153. 8.26.2 Zhejiang Tianhang Biotechnology Business Overview
  154. 8.26.3 Zhejiang Tianhang Biotechnology Bovine Blood Products Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Zhejiang Tianhang Biotechnology Bovine Blood Products Product Portfolio
  156. 8.26.5 Zhejiang Tianhang Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bovine Blood Products Value Chain Analysis
  2. 9.1.1 Bovine Blood Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bovine Blood Products Sales Mode & Process
  6. 9.2 Bovine Blood Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bovine Blood Products Distributors
  9. 9.2.3 Bovine Blood Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.